Certara Inc Equity-NMS: CERT

Healthcare

Health Information Services

Buy/Sell an entire stock
or a fraction.

Vested

Already an existing customer?

New User?

Open Your Free Demat Account And Start Trading Seamlessly

Loading, Please wait...

Error in Fetching Data, Please retry later.

No data available.

Previous close :	$9.77
Open :	$9.85
Today's high :	$10.46
Today's low :	$9.82
52W low :	$9.41
52W high :	$19.8702
1Y :	-35.19%
5Y :	-75.19%
EPS(TTM): :	-0.2
Shares O/S :	160.98 M
Market cap :	1.67 B

What is the share price of Certara Inc today?

Certara Inc (CERT) share price as of November 21, 2024, is $9.77. If you are investing from India, you can always check the valuation in the INR before investing.

Can Indian Investors purchase shares of Certara Inc?

Yes, Indian Investors can invest in the Certara Inc (CERT) Share by opening an international trading account with Angel One.

How can I purchase Certara Inc shares in India?

Purchasing Certara Inc (CERT) share from India can be done by:

Directly: By opening an international trading account with Angel One. The process would include KYC verification.
The account activation takes a few minutes to a few hours, after which you can start buying Certara Inc (CERT) by making deposits in US dollars.
Indirectly: By investing in mutual funds and Exchange Traded Funds (ETF) that offers exposure in global stocks.

Can I buy Fractional shares of Certara Inc?

Yes, you can purchase fractional shares of Certara Inc (CERT) or any other US company shares in Angel One for any dollar amount.

What is the market capitalization value of Certara Inc?

The market capitalization of Certara Inc on November 21, 2024, is $1.67 B.

In which sector Certara Inc belongs?

Certara Inc operates in the Healthcare sector, specifically in the Health Information Services industry.

What documents are required to invest in Certara Inc stocks?

In order to invest in Certara Inc (CERT) you will need Proof of Identification (Aadhaar, PAN, Passport etc.) and Proof of Address (Aadhaar, Voter Card etc.)

From start to end, the process is digital and can be seamless.

Certara, Inc. is engaged in model-informed drug development. The Company accelerates medicine using biosimulation software, technology and services to transform traditional drug discovery and development. It delivers software products and technology-driven services to customers to efficiently carry out and realize the full benefits of biosimulation in drug discovery, preclinical and clinical research, regulatory submissions and market access. Its regulatory science and market access software and services are underpinned by technologies such as regulatory submissions software, natural language processing and Bayesian analytics. It also develops scientific informatics software products used by the life sciences industry for in-silico research. It develops advanced modeling and biosimulation solutions used to predict the pharmacokinetic and pharmacodynamic properties. Its clients include 2,400 biopharmaceutical companies, academic institutions and regulatory agencies across 66 countries.